Tanzeum FDA Approval History
FDA Approved: Yes (First approved April 15, 2014)
Brand name: Tanzeum
Generic name: albiglutide
Dosage form: Injection
Company: GlaxoSmithKline
Treatment for: Diabetes, Type 2
Tanzeum (albiglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of type 2 diabetes.
Development timeline for Tanzeum
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.